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Environmental Health Research 
Implications of Methylmercury 
doi:10.1289/ehp.1103580
In “Adverse Effects of Methylmercury: 
Environmental Health Research Implications,” 
Grandjean et al. (2010) reviewed the scien-
tific discoveries of health risks resulting from 
methyl  mercury exposure, including the history 
of the Minamata disease incident. Although 
their title states “research implications,” the 
authors failed to convey some important 
caveats from the incident. 
First, Grandjean et al. (2010) explained the 
incident as if serious delays of the recognition 
of “the exact cause (methyl  mercury)” deferred 
the corrective action. However, recog  nition 
of an etiologic agent is not a necessary condi-
tion for prevention (Goodman et al. 1990). 
When source and transmission are identified, 
they must be eliminated even if the etiologic 
agent is unknown. In the case of Minamata 
disease, even in 1956 when the first patient 
was identified, eating contaminated seafood 
was determined to be a cause of the disease; 
this occurred 3 years before the etiologic agent 
was identified (Tsuda et al. 2009). Grandjean 
et al. (2010) cited Harada (2004), who wrote, 
However, with no specific causative substance 
[etiologic agent] determined, there was no legal 
basis for a ban on fishing. (Under Item 2 of the 
Food Sanitation Act, it was not possible to pro-
hibit fishing while the cause was undetermined.) 
However, in Japan, even with no specific eti-
ologic agent determined, the Food Sanitation 
Act has routinely been enacted when causal 
food and/or causal facility was determined.
Second, Grandjean et al. (2010) 
mentioned the “diagnostic difficulties” of 
methylmercury poisoning cases. Lack of 
investigation of the Minamata disease inci-
dent as food poisoning resulted in unneces-
sary diagnostic difficulties; such difficulties do 
not usually arise in food-poisoning incidents 
in Japan. In the case of Minamata disease, in 
1977 the Japanese Ministry of Environment 
(JME) established the criteria for diagnosis, 
which required combinations of signs that 
were advocated by the JME to be medically 
correct. However, the truth is that the JME 
recognized a lack of medical evidence on the 
criteria [Committee on Research and Human 
Rights/Japanese Society and Psychiatry and 
Neurology (CRHR-JSPN) 2003]. Moreover, 
medical researchers in Japan have pointed 
out that the criteria were medically incorrect 
(CRHR-JSPN 1998). The “diagnostic diffi-
culties” may have obscured who was affected 
and had neurological signs. 
Third, Grandjean et al. (2010) stated 
that, “Only in 2009 was a law enacted to 
provide compensation to most of the remain-
ing group of victims.” However, it was 
not compensation. For Minamata disease, 
unless the affected persons are diagnosed by 
the above-mentioned criteria, they are not 
counted as patients and are thus not properly 
compensated. About 2,200 patients have 
been diagnosed with Minamata disease and 
have been compensated, whereas at least sev-
eral tens of thousands of victims who have 
neurological signs charac  teristic of methyl-
mercury poisoning have not been recog  nized 
as patients and have not been not properly 
compensated (McCurry 2006).
Fourth, Grandjean et al. (2010) described 
the “scientific account” of the cat experiment 
in 1959, which was published after a 40-year 
delay (Eto et al. 2001). However, the report 
provided only pathological findings, and 
the detailed explanation of the cat experi-
ment had already been published in 1965 
(Tomita 1965). The latter would be enough 
for prevention and control.
Finally, because the JME and local 
govern  ments have been defendants in 
Minamata disease lawsuits, research funds 
from JME and the local govern  ments may 
affect researchers’ attitudes, possibly causing 
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We thank Tsuda et al. for sharing their 
views. Along with their previous publications 
on Minamata disease, we find their com-
ments useful as a complement to our brief 
historical review of the mass poisonings in 
Japan and associated events (Grandjean et al. 
2010). However, the specific issues raised in 
their letter do not affect our conclusions on 
the research implications of the history of 
methyl  mercury science. 
P.G. has provided paid expert testimony on 
mercury toxicology in a legal case concerning 
environmental pollution from coal-powered 
power plants. The other authors declare that they 
have no actual or potential competing   financial 
interests. 
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Particulate Matter–Induced Health 
Effects: Who Is Susceptible?
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We read with great interest a recent review 
by Sacks et al. (2011) and would like to 
add some comments to facilitating effects 
of particulate matter (PM) on pre  existing 
respiratory diseases. First of all, the adverse 
effects of PM/diesel exhaust particles (DEP) 
on chronic obstructive pulmonary disease 
(COPD) patho  physiology seem to be con-
troversial. Subjects with pulmonary emphy-
sema are epidemiologically susceptible to 
PM (Dockery et al. 1993; Euler et al. 1987; 
MacNee and Donaldson 2003; Thishan 
Dharshana and Coowanitwong 2008). 
Further, as noted by Sacks et al. (2011), 
Lopes et al. (2009) have experimentally 
shown that chronic (2 months) exposure 
to an ambient level (mean concentration, 
34 µg/m3) of PM10 (PM < 10 µm in aero-
dynamic diameter) worsens murine emphy-
sema induced by papain. In contrast, in our 
previous study (Inoue et al. 2010) we did not 
obtain apparent evidence that a single intra-
tracheal administration of DEP [200 µg/
animal, a dose high enough to worsen infec-
tious lung injury (Takano et al. 2002)] exac-
erbates porcine pancreatic elastase–elicited 
pulmonary emphysema in mice. Possible 
explanations for this opposite phenomenon 
may include differences in animal strains or 
species, pathological conditions (type and/or   
degree of emphysematous inflammation), 
and/or DEP exposure protocols (route, dose, 
timing, duration, and/or terminal point). 
Additional in-depth studies will be required 
to conclude PM/DEP has adverse effects on 
COPD pathophysiology. 
Secondly, from a biological point of 
view, pulmonary fibrosis (PF) should be 
added to the list of PM-susceptible respi-
ratory diseases. Recently, Decologne et al. 
(2010) showed that exposure to carbon black 
nano  particles exacerbates bleomycin-induced 
PF in mice. More recently, we demonstrated 
that a single intra  tracheal instillation of tiny 
carbon black nano  particles (14 nm) at a dose 
of 10 µg/mouse aggravates PF, suggesting 
that exposure to trace amounts of PM can 
exacerbate patho  physiology (Kamata et al. 
2011). Accordingly, careful attention should 
be paid to PF patients who are at risk of 
environmental and occupational exposure 
to PM, although further basic and clinical 
research is necessary. 
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Editor’s note: In accordance with journal 
policy, Sacks et al. were asked whether they 
wanted to respond to this letter, but they chose 
not to do so.
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